Hernández D et al. |
Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression. |
2007 |
Transplantation |
pmid:17893603
|
Schwartz JJ et al. |
Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. |
2007 |
Transplantation |
pmid:17893604
|
Tydén G et al. |
Implementation of a Protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations. |
2007 |
Transplantation |
pmid:17496528
|
Cvetkovic M et al. |
The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. |
1994 |
Transplantation |
pmid:7513912
|
Boukriche Y et al. |
Severe axonal polyneuropathy after a FK506 overdosage in a lung transplant recipient. |
2001 |
Transplantation |
pmid:11740402
|
Anderson PO |
Tacrolimus and breastfeeding. |
1998 |
Transplantation |
pmid:9539100
|
Gathogo E et al. |
Impact of Tacrolimus Compared With Cyclosporin on the Incidence of Acute Allograft Rejection in Human Immunodeficiency Virus-Positive Kidney Transplant Recipients. |
2016 |
Transplantation |
pmid:26413990
|
Xue F et al. |
Immune cell functional assay in monitoring of adult liver transplantation recipients with infection. |
2010 |
Transplantation |
pmid:20010326
|
Papadopoulos-Köhn A et al. |
Daily low-dose tacrolimus is a safe and effective immunosuppressive regimen during telaprevir-based triple therapy for hepatitis C virus recurrence after liver transplant. |
2015 |
Transplantation |
pmid:25208324
|
Ciancio G et al. |
Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients. |
2002 |
Transplantation |
pmid:11965039
|
Jain A et al. |
FK506 and pregnancy in liver transplant patients. |
1993 |
Transplantation |
pmid:7506459
|
Lenaers JI et al. |
Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients. |
2006 |
Transplantation |
pmid:17102764
|
Barraclough KA et al. |
NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. |
2012 |
Transplantation |
pmid:23095803
|
Diem HV et al. |
Pediatric liver transplantation for biliary atresia: results of primary grafts in 328 recipients. |
2003 |
Transplantation |
pmid:12777858
|
Ito A et al. |
Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning. |
1997 |
Transplantation |
pmid:9311715
|
Smets F et al. |
Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. |
2002 |
Transplantation |
pmid:12042647
|
Heidt S et al. |
Effects of immunosuppressive drugs on purified human B cells: evidence supporting the use of MMF and rapamycin. |
2008 |
Transplantation |
pmid:19005412
|
van Rijen MM et al. |
CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. |
2002 |
Transplantation |
pmid:12042657
|
Serón D et al. |
Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. |
2007 |
Transplantation |
pmid:17353788
|
Higgins RM et al. |
Acute rejection after renal transplantation is reduced by approximately 50% by prior therapeutic blood transfusions, even in tacrolimus-treated patients. |
2004 |
Transplantation |
pmid:14966430
|
Araki M et al. |
Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs. |
2006 |
Transplantation |
pmid:16477217
|
Vivarelli M et al. |
Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma. |
2010 |
Transplantation |
pmid:20098287
|
Pruvot FR and Noel C |
Comment on "Pregnancy after liver transplantation under tacrolimus" by Jain et al. |
1998 |
Transplantation |
pmid:9625033
|
Shackleton CR et al. |
Lack of correlation between the magnitude of preservation injury and the incidence of acute rejection, need for OKT3, and conversion to FK506 in cyclosporine-treated primary liver allograft recipients. |
1995 |
Transplantation |
pmid:7570950
|
Wannhoff A et al. |
Increased levels of rivaroxaban in patients after liver transplantation treated with cyclosporine A. |
2014 |
Transplantation |
pmid:25022236
|
Pacifico L et al. |
Tacrolimus and food allergy. |
2003 |
Transplantation |
pmid:14688538
|
Gullestad L et al. |
Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial. |
2010 |
Transplantation |
pmid:20061999
|
Glicklich D et al. |
Chronic renal allograft rejection: no response to mycophenolate mofetil. |
1998 |
Transplantation |
pmid:9721811
|
Calandra S |
Sinus arrest during tacrolimus treatment: was the QT interval prolonged? |
1998 |
Transplantation |
pmid:9721813
|
Srinivas TR et al. |
The impact of mycophenolate mofetil on long-term outcomes in kidney transplantation. |
2005 |
Transplantation |
pmid:16251854
|
Fridell JA et al. |
Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. |
2002 |
Transplantation |
pmid:12499888
|
Marks WH et al. |
Asialoglycoprotein/asialoglycoprotein receptor (AGP-AGPr) interaction is an important mechanism for the uptake of FK506 by hepatocytes. |
1997 |
Transplantation |
pmid:9020333
|
Kainz A et al. |
Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. |
2000 |
Transplantation |
pmid:11152103
|
Gillard P et al. |
Early alteration of kidney function in nonuremic type 1 diabetic islet transplant recipients under tacrolimus-mycophenolate therapy. |
2014 |
Transplantation |
pmid:24770614
|
Brito-Costa A et al. |
Factors Associated With Changes in Body Composition Shortly After Orthotopic Liver Transplantation: The Potential Influence of Immunosuppressive Agents. |
2016 |
Transplantation |
pmid:27136260
|
Bazerbachi F et al. |
Pancreas-after-kidney versus synchronous pancreas-kidney transplantation: comparison of intermediate-term results. |
2013 |
Transplantation |
pmid:23183776
|
Tsamandas AC et al. |
Central venulitis in the allograft liver: a clinicopathologic study. |
1997 |
Transplantation |
pmid:9256183
|
Tricot L et al. |
Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. |
2005 |
Transplantation |
pmid:16371923
|
Jin L et al. |
Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats. |
2018 |
Transplantation |
pmid:29319618
|
|
Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. Drug levels in PHAs who receive liver transplants. |
2003 Apr-May |
TreatmentUpdate |
pmid:17216847
|
Kunz J and Hall MN |
Cyclosporin A, FK506 and rapamycin: more than just immunosuppression. |
1993 |
Trends Biochem. Sci. |
pmid:7694398
|
Cardenas ME et al. |
Signal-transduction cascades as targets for therapeutic intervention by natural products. |
1998 |
Trends Biotechnol. |
pmid:9807840
|
Snyder SH et al. |
Neural actions of immunophilin ligands. |
1998 |
Trends Pharmacol. Sci. |
pmid:9509898
|
Liu J |
FK506 and ciclosporin: molecular probes for studying intracellular signal transduction. |
1993 |
Trends Pharmacol. Sci. |
pmid:7692652
|
Chang JY et al. |
FK506 and rapamycin: novel pharmacological probes of the immune response. |
1991 |
Trends Pharmacol. Sci. |
pmid:1710854
|
Sommerer C et al. |
Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial. |
2016 |
Trials |
pmid:26888217
|
Nashan B et al. |
Evaluating the efficacy, safety and evolution of renal function with early initiation of everolimus-facilitated tacrolimus reduction in de novo liver transplant recipients: Study protocol for a randomized controlled trial. |
2015 |
Trials |
pmid:25873064
|
Bajetta E et al. |
Merkel cell carcinoma after liver transplantation: a case report. |
2007 May-Jun |
Tumori |
pmid:17679476
|
Vennarecci G et al. |
[Acute liver toxicity of antiretroviral therapy (HAART) after liver transplantation in a patient with HIV-HCV coinfection and associated hepatocarcinoma (HCC)]. |
2003 Jul-Aug |
Tumori |
pmid:12903579
|
Dinçkan A et al. |
Evaluation of the first 100 liver transplantations. |
2008 |
Turk J Gastroenterol |
pmid:18386237
|